Learn about polymyalgia rheumatica (PMR) symptoms and treatment. Understand the sudden start of pain and how it is different from arthritis.

For patients with polymyalgia rheumatica with relapse during tapering of glucocorticoid therapy, treatment with sarilumab, the human monoclonal antibody that binds to the interleukin-6 receptor α, is ...

Findings showed secukinumab demonstrated statistically significant and clinically meaningful sustained remission at week 52 vs placebo. Topline data were announced from a phase 3 trial evaluating ...

As IL-6 inhibition comes into practice for PMR, research advances on other therapeutic mechanisms of action, from IL-17 to ...

MELBOURNE, Australia — People with relapsing polymyalgia rheumatica (PMR) who were treated with the anti-interleukin (IL)-17A monoclonal antibody secukinumab had twice the rate of sustained remission ...